2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
3137
Neoplasms
2472
Carcinoma, Non-Small-Cell Lung
1886
Prostatic Neoplasms
1635
Colorectal Neoplasms
1435
Lung Neoplasms
1308
Multiple Myeloma
939
Neoplasm Metastasis
928
Leukemia, Myeloid, Acute
884
Pancreatic Neoplasms
856
Ovarian Neoplasms
810
Melanoma
791
Carcinoma, Hepatocellular
742
Stomach Neoplasms
648
Brain Neoplasms
641
Recurrence
640
Squamous Cell Carcinoma of Head and Neck
639
Head and Neck Neoplasms
612
Glioblastoma
573
Lymphoma
550
Uterine Cervical Neoplasms
545
Triple Negative Breast Neoplasms
513
Precursor Cell Lymphoblastic Leukemia-Lymphoma
509
Carcinoma, Renal Cell
504
Hematologic Neoplasms
466
Endometrial Neoplasms
466
Urinary Bladder Neoplasms
462
Colonic Neoplasms
446
Lymphoma, Non-Hodgkin
439
Sarcoma
436
Interventions
4-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Embolism and Thrombosis
×
1 year
×
Clear all
NCT04657120
2025-12-23
HYDRA
Leiden University Medical Center
Phase NA
Completed
698 enrolled